Mangoceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Mangoceuticals has a total shareholder equity of $13.4M and total debt of $187.5K, which brings its debt-to-equity ratio to 1.4%. Its total assets and total liabilities are $14.8M and $1.4M respectively.
Key information
1.4%
Debt to equity ratio
US$187.50k
Debt
Interest coverage ratio | n/a |
Cash | US$90.85k |
Equity | US$13.39m |
Total liabilities | US$1.40m |
Total assets | US$14.79m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MGRX's short term assets ($104.1K) do not cover its short term liabilities ($1.4M).
Long Term Liabilities: MGRX's short term assets ($104.1K) exceed its long term liabilities ($12.2K).
Debt to Equity History and Analysis
Debt Level: MGRX's net debt to equity ratio (0.7%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if MGRX's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MGRX has sufficient cash runway for 0 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: MGRX is forecast to have sufficient cash runway for 0 months based on free cash flow estimates, but has since raised additional capital.